Three genes, i.e., CLEC7A, CLEC10A, and HAPLN3 have been reported to exhibit prognostic significance with respect to melanoma for the first time, while HCP5 has been reported to inhibit the development of cutaneous melanoma (42). This evidence concerns the gene HCP5 and melanoma.